KR20020086558A - 다공성 필터를 이용하는 생리활성 시료물질의 측정방법 - Google Patents
다공성 필터를 이용하는 생리활성 시료물질의 측정방법 Download PDFInfo
- Publication number
- KR20020086558A KR20020086558A KR1020027010881A KR20027010881A KR20020086558A KR 20020086558 A KR20020086558 A KR 20020086558A KR 1020027010881 A KR1020027010881 A KR 1020027010881A KR 20027010881 A KR20027010881 A KR 20027010881A KR 20020086558 A KR20020086558 A KR 20020086558A
- Authority
- KR
- South Korea
- Prior art keywords
- ligand
- solution
- bound
- porous filter
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 239000000126 substance Substances 0.000 title claims abstract description 22
- 239000003446 ligand Substances 0.000 claims abstract description 96
- 238000005259 measurement Methods 0.000 claims abstract description 70
- 239000000523 sample Substances 0.000 claims abstract description 70
- 239000002516 radical scavenger Substances 0.000 claims abstract description 37
- 102000004190 Enzymes Human genes 0.000 claims abstract description 32
- 108090000790 Enzymes Proteins 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 16
- 230000000975 bioactive effect Effects 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000009739 binding Methods 0.000 claims abstract description 9
- 239000011149 active material Substances 0.000 claims abstract description 7
- 239000013566 allergen Substances 0.000 claims description 42
- 230000001745 anti-biotin effect Effects 0.000 claims description 28
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 22
- 239000013543 active substance Substances 0.000 claims description 21
- 125000006850 spacer group Chemical group 0.000 claims description 12
- 239000011616 biotin Substances 0.000 claims description 11
- 229960002685 biotin Drugs 0.000 claims description 11
- 235000020958 biotin Nutrition 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- 239000012488 sample solution Substances 0.000 claims description 10
- 230000001766 physiological effect Effects 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 230000004071 biological effect Effects 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 30
- 238000012360 testing method Methods 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 112
- 239000007790 solid phase Substances 0.000 description 46
- 239000007787 solid Substances 0.000 description 29
- 239000000872 buffer Substances 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 239000000427 antigen Substances 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 17
- 239000002504 physiological saline solution Substances 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 15
- 238000002156 mixing Methods 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 239000003381 stabilizer Substances 0.000 description 9
- 241000283707 Capra Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 239000002981 blocking agent Substances 0.000 description 7
- 230000001900 immune effect Effects 0.000 description 7
- 238000000691 measurement method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 238000009736 wetting Methods 0.000 description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- 239000003365 glass fiber Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000223600 Alternaria Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 244000281762 Chenopodium ambrosioides Species 0.000 description 2
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 2
- 235000005490 Chenopodium botrys Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 244000052363 Cynodon dactylon Species 0.000 description 2
- 240000004585 Dactylis glomerata Species 0.000 description 2
- 241000238713 Dermatophagoides farinae Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 241000746983 Phleum pratense Species 0.000 description 2
- 244000090125 Solidago odora Species 0.000 description 2
- 235000010394 Solidago odora Nutrition 0.000 description 2
- 235000000914 Solidago virgaurea Nutrition 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000006287 biotinylation Effects 0.000 description 2
- 238000007413 biotinylation Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 240000004178 Anthoxanthum odoratum Species 0.000 description 1
- 235000014251 Anthoxanthum odoratum Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 235000002359 Betula platyphylla var japonica Nutrition 0.000 description 1
- 240000004183 Bongardia chrysogonum Species 0.000 description 1
- HKPYPSRJESKBLF-UHFFFAOYSA-N CC(=O)C.NCCC[SiH2]OCC Chemical compound CC(=O)C.NCCC[SiH2]OCC HKPYPSRJESKBLF-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 206010037075 Protozoal infections Diseases 0.000 description 1
- 244000197975 Solidago virgaurea Species 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 102000004987 Troponin T Human genes 0.000 description 1
- 108090001108 Troponin T Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229910052699 polonium Inorganic materials 0.000 description 1
- HZEBHPIOVYHPMT-UHFFFAOYSA-N polonium atom Chemical compound [Po] HZEBHPIOVYHPMT-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2000-00045380 | 2000-02-23 | ||
| JP2000045380A JP4545869B2 (ja) | 2000-02-23 | 2000-02-23 | 多孔性フィルタを用いる生理活性試料物質の測定方法 |
| PCT/JP2001/001196 WO2001063283A1 (en) | 2000-02-23 | 2001-02-20 | Method of measuring physiologically active sample substance by using porous filter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20020086558A true KR20020086558A (ko) | 2002-11-18 |
Family
ID=18567975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020027010881A Ceased KR20020086558A (ko) | 2000-02-23 | 2001-02-20 | 다공성 필터를 이용하는 생리활성 시료물질의 측정방법 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP4545869B2 (https=) |
| KR (1) | KR20020086558A (https=) |
| AU (1) | AU2001232350A1 (https=) |
| TW (1) | TWI275796B (https=) |
| WO (1) | WO2001063283A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4739755B2 (ja) * | 2002-10-11 | 2011-08-03 | ゼットビーエックス コーポレーション | 診断装置 |
| JP4771941B2 (ja) | 2004-04-21 | 2011-09-14 | 株式会社エイアンドティー | 免疫学的定量法と試薬 |
| WO2006094665A1 (en) | 2005-03-08 | 2006-09-14 | Kenton Srl | Chimeric recombinant antigens of toxoplasma gondii |
| JP2007121095A (ja) * | 2005-10-27 | 2007-05-17 | Toyobo Co Ltd | 非特異反応が抑制されるように改良された測定容器 |
| JP4904182B2 (ja) * | 2007-03-19 | 2012-03-28 | 財団法人電力中央研究所 | カドミウム、鉛、又は３価クロムの免疫学的定量方法及びそれらの免疫学的定量装置、並びに、それらに用いるカドミウム、鉛、又は３価クロム錯体固定化膜 |
| JP5118479B2 (ja) * | 2007-12-28 | 2013-01-16 | 田中貴金属工業株式会社 | イムノクロマト分析法及びイムノクロマト分析キット |
| EP2108656A1 (en) | 2008-03-19 | 2009-10-14 | Beninati, Concetta | Antigenic protein fragments of streptococcus pneumoniae |
| WO2010041595A1 (ja) * | 2008-10-08 | 2010-04-15 | 東洋紡績株式会社 | 生理活性物質測定システム |
| JP5716501B2 (ja) * | 2011-04-04 | 2015-05-13 | 東洋紡株式会社 | 検体の前処理方法 |
| JP6531307B2 (ja) * | 2015-04-08 | 2019-06-19 | 株式会社パートナーファーム | 固相反応容器及びこれを用いた測定方法 |
| JP6943371B2 (ja) * | 2017-04-19 | 2021-09-29 | 国立大学法人福井大学 | 尿中の急性腎障害マーカーの測定方法 |
| ES3035098T3 (en) | 2018-02-02 | 2025-08-28 | Nippon Chemiphar Co | Biochemical reaction substrate and analysis device |
| KR20220041854A (ko) | 2019-08-07 | 2022-04-01 | 가부시키가이샤 파트너 펌 | 고상 반응 용기 및 이것을 사용한 측정 방법 |
| WO2021095858A1 (ja) * | 2019-11-14 | 2021-05-20 | インターメディック株式会社 | 生理活性物質の測定方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4496654A (en) * | 1983-04-08 | 1985-01-29 | Quidel | Detection of HCG with solid phase support having avidin coating |
| US4632901A (en) * | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
| DE3620653A1 (de) * | 1986-06-20 | 1987-12-23 | Boehringer Mannheim Gmbh | Verfahren zur herstellung eines immunreaktiven traegermaterials fuer die heterogene immunologische analyse |
| CA1333883C (en) * | 1988-04-07 | 1995-01-10 | Shashidhara H. M. Murthy | Immunoassay utilizing biotin bridge with universal solid phase |
| JPH01312463A (ja) * | 1988-06-10 | 1989-12-18 | Dai Ichi Pure Chem Co Ltd | 免疫学的測定法 |
| JP3134231B2 (ja) * | 1991-04-16 | 2001-02-13 | 東洋紡績株式会社 | 固相生物学的特異反応測定法およびそのための器具 |
| JPH10253632A (ja) * | 1997-03-10 | 1998-09-25 | Nissui Pharm Co Ltd | 分析方法、キット及び装置 |
| JPH11201969A (ja) * | 1998-01-14 | 1999-07-30 | Wakamoto Pharmaceut Co Ltd | 簡易遊離ヘモグロビン測定方法および測定用キット |
| JPH11326326A (ja) * | 1998-05-13 | 1999-11-26 | Dainippon Printing Co Ltd | 免疫検査体 |
| JP2000088851A (ja) * | 1998-09-10 | 2000-03-31 | Internatl Reagents Corp | 生物学的特異反応測定法及び装置 |
-
2000
- 2000-02-23 JP JP2000045380A patent/JP4545869B2/ja not_active Expired - Lifetime
-
2001
- 2001-02-20 KR KR1020027010881A patent/KR20020086558A/ko not_active Ceased
- 2001-02-20 WO PCT/JP2001/001196 patent/WO2001063283A1/ja not_active Ceased
- 2001-02-20 AU AU2001232350A patent/AU2001232350A1/en not_active Abandoned
- 2001-08-02 TW TW090118884A patent/TWI275796B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001063283A1 (en) | 2001-08-30 |
| JP2001235471A (ja) | 2001-08-31 |
| TWI275796B (en) | 2007-03-11 |
| AU2001232350A1 (en) | 2001-09-03 |
| JP4545869B2 (ja) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI92883B (fi) | Testimenetelmä ja reagenssikitti sitä varten | |
| US8846319B2 (en) | Lateral flow strip assay with immobilized conjugate | |
| US5158869A (en) | Analyte determination using comparison of juxtaposed competitive and non-competitive elisa results and device therefore | |
| JP4209978B2 (ja) | ポリエチレングリコール誘導化生体分子及び不均質検出法におけるその使用 | |
| US20130102063A1 (en) | Small molecules and protein analysis devices based on molecular imprinted polymers | |
| KR20020086558A (ko) | 다공성 필터를 이용하는 생리활성 시료물질의 측정방법 | |
| JPH0566547B2 (https=) | ||
| WO1998040740A1 (fr) | Procede, trousse et dispositif d'analyse | |
| WO2009083975A2 (en) | Small molecules and protein analysis devices based on molecular imprinted polymers | |
| US6653066B1 (en) | Device and method for detecting polyvalent substances | |
| JPH1164336A (ja) | 免疫クロマトグラフィーによる分析対象物の検出方法 | |
| JP4627607B2 (ja) | 複数項目及び総含有量の同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ | |
| US20070092978A1 (en) | Target ligand detection | |
| JP2011519034A (ja) | 生物学的起原の出発材料中に見出される複数の検体のスタンダードを作成する方法 | |
| JP4531252B2 (ja) | 粒子を使用した分析法および本方法を行うための試験キット | |
| JP4437211B2 (ja) | 免疫クロマトグラフィーを用いた測定方法およびそれに用いる検体分析用具 | |
| CN116027035B (zh) | 一种用于提高hiv1/2尿液胶体金免疫层析检测准确率的试剂盒及制备方法 | |
| US20100285607A1 (en) | Method for detecting and quantifying analytes on a solid support with liposome-encapsulated fluorescent molecules | |
| JPH10185921A (ja) | 免疫学的定量装置 | |
| Fici et al. | A protein multiplex microarray substrate with high sensitivity and specificity | |
| JP5065355B2 (ja) | 多孔性フィルタを用いる生理活性試料物質の測定方法 | |
| US20030092093A1 (en) | Extrasomatic diagnostics | |
| JPH06505803A (ja) | マルチテスト免疫化学的試薬及びその使用方法 | |
| RU2314827C2 (ru) | Способ получения конъюгата для стереоспецифического анализа | |
| JP2001228156A (ja) | 梅毒抗体検出用免疫分析装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20020821 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20051122 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061115 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070514 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20061115 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |